General Documents

Documents issued by JPAC

These documents are issued by JPAC and/or its Standing Advisory Committees. A review system exists to ensure documents are regularly reviewed.

• Blood Component Request and Allocation Process (March 2022)
   
• Deviations from the specified storage temperature and interruption of agitation of platelets – practical considerations (June 2020)
   
• Deviations from 4°C temperature storage for red cells: Effect on viability and bacterial growth (June 2016)
   
• Deviations from the specified storage temperature for Fresh-Frozen Plasma (FFP) whilst in its frozen state (March 2021)
   
• Look Back and Trace Back (March 2019)
   
• Options for Human T-Lymphotropic Virus (HTLV) screening with the UK Blood Services (October 2015)
   
• Post-donation management of Blood Donors with nerve injury related to donation (November 2020)
   
• Road map for UK Blood Services to manage a hepatitis A outbreak (November 2019)
   
• Recommendations for removal of the upper age limit for regular whole blood and component donors (November 2008)
   
• Specification for the future labelling of Blood Components prepared in the UK (November 2021)
   
• The Use of G-CSF in Unrelated Volunteer Stem Cell Donors (June 2007)
   
• Trial-Provisional component specifications (February 2019)
   
• Validation of plasma and platelet pathogen inactivation (March 2019)
   
• Validation of dried plasma (March 2022)
   

Documents relevant to the UK blood supply (not issued by JPAC)

These documents affect the UK Blood Transfusion Services but are not issued by JPAC. While JPAC make every effort to ensure the latest version of these documents are published, JPAC cannot guarantee that these documents are regularly reviewed nor that the latest version is published here. Should you be aware of a more up to date version of a document we would appreciate notification by contacting JPACOffice@nhsbt.nhs.uk.

FAIR (For the Assessment of Individualised Risk)

• FAIR I: Can donor selection policy move from a population-based donor selection policy to one based on a more individualised risk assessment? (December 2020)
   
• FAIR II: An assessment of the evidence for the donor selection question asking about sexual partners who may have had sex in areas of the world where HIV is very common (March 2021)
   
• FAIR III: Can the policy recommendations from FAIR be safely and effectively applied to tissue and cell donors across the UK? (May 2022)

Other documents

• The effects of pen ink and surface disinfectants on red blood cells stored in plasticized polyvinylchloride transfusion bags (Uy RJ, et al. Transfusion. 2023)
   
• Spongiform Encephalopathy Advisory Committee (SEAC) position statements 
   
• Position Paper on UK Plasma - UK Forum (2022)